CompoAtlas

Almay Clear Complexion Blemish Armor

Natural health product licensed in Canada

Licence holder
Revlon Canada Inc.
NPN or DIN-HM
80083187
Status
Inactive licence
Licence date
15 February 2018
Revision date
Not provided
Form
Solution
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Acide 2-hydroxybenzoïque

Source : Acide salicylique

2 %

Non-medicinal ingredients

Acide citrique, Phénoxyéthanol, Caprylyl glycol, Extrait d'écorce d'Enantia Chlorantha, Gomme de sclérotium, Protéine végétale hydrolysée, Alcool dénat., EDTA trisodium, Butylène glycol, Ethylhexylglycérine, Copolymères d'acrylates/de styrènes, Gomme de xanthane, Poly(silicone-11), Acide sorbique, Polymethylsilsesquioxane, Isomérate de saccharide, Déshydroacétate de sodium, Acétate de d-alpha tocophéryle, Phosphatidylcholine hydrogénée, Eau, Silice, Laureth-12

PopulationAgeQuantity per servingFrequency
Adolescentesminimum: 9 years ; maximum: 13 yearsNot specifiedNot specified
Adultes et adolescentsminimum: 13 yearsNot specifiedNot specified

Uses authorised in Canada

For treatment/management of acne. Helps clear and prevent acne blemishes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80083187

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line